AGMB
AgomAb Therapeutics NV · Healthcare · Market cap $316.4M(Price slightly stale)
Insiders bought $400K net in the last 90 days ·0 sellers, 3 buyers· latest Form 4 filed Oct 22, 2026
Insider Buying
$400K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Oct 22, 2026
Epstein David R
AgomAb Therapeutics NV (AGMB) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Oct 22, 2026.
Inside the rolling window, 3 insiders at AgomAb Therapeutics NV reported 7 open-market purchases totaling $400K and no open-market sales. The most active filer is Director Epstein David R with 4 filings. Insiders have net bought $400K over the trailing 6 months. The most recent open-market filing is a purchase of 10,000 shares by Director Epstein David R, dated Oct 21, 2026, worth $89K.
- Industry:Biotechnology
- CEO:Tim Knotnerus
- Employees:62
- HQ:Antwerp, VL, BE
- IPO:2026-02-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 10,000 | $89K | Oct 22 | — | SEC ↗ | |
| Director | Purchase | 5,000 | $45K | Oct 9 | cluster+2.0% | SEC ↗ | |
| Director | Purchase | 5,000 | $43K | Oct 7 | cluster+5.2% | SEC ↗ | |
| Director | Purchase | 5,000 | $44K | Oct 7 | cluster+5.2% | SEC ↗ | |
Kemula Pierre Thadee VictorFirst filing | Chief Financial Officer | Purchase | 10,000 | $86K | Oct 7 | cluster+5.2% | SEC ↗ |
Knotnerus Tim JasperFirst filing | Chief Executive Officer | Purchase | 6,000 | $51K | Oct 7 | cluster+5.2% | SEC ↗ |
Knotnerus Tim JasperFirst filing | Chief Executive Officer | Purchase | 5,000 | $44K | Oct 7 | cluster+5.2% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does AGMB have?
AgomAb Therapeutics NV (AGMB) has 5 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Oct 22, 2026.
When was the most recent SEC Form 4 filing for AGMB?
The most recent Form 4 filing for AGMB on Tracefour is dated Oct 22, 2026.
Who is the most active insider at AGMB?
The most active SEC Form 4 filer at AGMB in the rolling window is Director Epstein David R, with 4 filings.
What is the net insider flow at AGMB over the last 6 months?
Over the trailing 180 days, insiders at AGMB have net bought $400K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AGMB in the current window?
Inside the rolling window, insiders at AGMB bought $400K and sold $0 based on SEC Form 4 filings.
Can I get alerts for AGMB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AgomAb Therapeutics NV (AGMB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AgomAb Therapeutics NV is in the Healthcare sector.